UniSa - IRIS Institutional Research Information System

SELLERI, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.086
AS - Asia 22.763
EU - Europa 12.075
SA - Sud America 1.544
Continente sconosciuto - Info sul continente non disponibili 737
AF - Africa 257
OC - Oceania 24
Totale 61.486
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.650
HK - Hong Kong 13.362
SG - Singapore 4.329
FI - Finlandia 4.165
IT - Italia 3.031
CN - Cina 2.153
VN - Vietnam 1.267
UA - Ucraina 1.206
BR - Brasile 1.143
DE - Germania 1.080
RU - Federazione Russa 761
IE - Irlanda 442
FR - Francia 401
KR - Corea 340
TR - Turchia 307
IN - India 276
GB - Regno Unito 222
CA - Canada 211
SE - Svezia 195
ES - Italia 183
BD - Bangladesh 175
AR - Argentina 168
AT - Austria 108
JP - Giappone 105
MX - Messico 105
IQ - Iraq 76
ZA - Sudafrica 75
NL - Olanda 63
PL - Polonia 60
PK - Pakistan 57
EC - Ecuador 55
ID - Indonesia 48
VE - Venezuela 44
CZ - Repubblica Ceca 43
CO - Colombia 42
MA - Marocco 37
UZ - Uzbekistan 34
SA - Arabia Saudita 31
CL - Cile 30
MY - Malesia 30
ET - Etiopia 28
EU - Europa 28
PY - Paraguay 25
JO - Giordania 24
EG - Egitto 23
JM - Giamaica 21
PH - Filippine 21
KE - Kenya 20
AE - Emirati Arabi Uniti 19
LT - Lituania 19
TN - Tunisia 19
AU - Australia 17
PE - Perù 17
HN - Honduras 16
CR - Costa Rica 15
DO - Repubblica Dominicana 15
DZ - Algeria 14
KG - Kirghizistan 14
KZ - Kazakistan 12
CH - Svizzera 11
NI - Nicaragua 11
UY - Uruguay 10
BE - Belgio 9
PA - Panama 9
AL - Albania 8
OM - Oman 8
AZ - Azerbaigian 7
IL - Israele 7
AO - Angola 6
BO - Bolivia 6
LB - Libano 6
LV - Lettonia 6
MD - Moldavia 6
NG - Nigeria 6
NP - Nepal 6
NZ - Nuova Zelanda 6
SY - Repubblica araba siriana 6
TH - Thailandia 6
BB - Barbados 5
GT - Guatemala 5
HR - Croazia 5
HU - Ungheria 5
PR - Porto Rico 5
PS - Palestinian Territory 5
RS - Serbia 5
SN - Senegal 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
BZ - Belize 4
GR - Grecia 4
KW - Kuwait 4
LU - Lussemburgo 4
LY - Libia 4
MK - Macedonia 4
QA - Qatar 4
RO - Romania 4
SC - Seychelles 4
AM - Armenia 3
BH - Bahrain 3
CI - Costa d'Avorio 3
Totale 60.710
Salva come PNG Salva come JPEG
Città #
Hong Kong 13.326
Ann Arbor 4.703
Helsinki 3.835
Woodbridge 2.447
Singapore 2.210
San Jose 1.893
Jacksonville 1.462
Chandler 1.347
Milan 1.219
Houston 1.193
Princeton 1.164
Ashburn 1.156
Dallas 1.146
Wilmington 1.112
Beijing 455
Munich 451
Council Bluffs 441
Dong Ket 422
Dublin 419
Rome 347
Lauterbourg 345
Ho Chi Minh City 293
The Dalles 284
Andover 283
Nanjing 261
Izmir 248
Boardman 246
Los Angeles 234
Moscow 219
Salerno 213
Santa Clara 204
Hanoi 194
New York 189
Pellezzano 171
Naples 155
Düsseldorf 145
São Paulo 121
Valencia 120
Fairfield 100
Nuremberg 95
Shenyang 90
Orem 88
Turin 88
Changsha 86
Nanchang 86
Jiaxing 81
Figino 80
Tokyo 80
Hebei 77
Brooklyn 74
Frankfurt am Main 69
Chennai 67
Buffalo 66
Chicago 65
Turku 62
Montreal 60
Washington 59
Redwood City 55
Warsaw 55
London 53
Norwalk 49
Tianjin 49
Johannesburg 46
Seattle 45
Vienna 45
Manchester 44
Pune 42
Mexico City 41
Rio de Janeiro 41
Amsterdam 39
Denver 39
Phoenix 39
Toronto 39
Atlanta 38
Boston 37
Dearborn 37
Brno 36
Da Nang 36
Napoli 36
Cambridge 34
Columbus 34
Haiphong 34
San Francisco 34
Stockholm 33
Mumbai 32
Tashkent 32
Brasília 31
Memphis 30
Addis Ababa 28
Baghdad 28
Belo Horizonte 28
Shanghai 28
San Diego 27
Guangzhou 25
Jinan 23
Lahore 23
Dhaka 22
Amman 21
Charlotte 21
Curitiba 21
Totale 47.676
Salva come PNG Salva come JPEG
Nome #
3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An in-vitro study of Tenogenic events on Wharton’s Jelly Mesenchymal stem cells 2.033
3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential 1.989
The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. 914
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 895
Computer aided identification of small molecules interfering with the functional interaction of the urokinase receptor with fMLP receptors 866
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 715
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 671
Endocrine disorders during the first year after autologous stem-cell transplant. 595
Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. 591
Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples 584
Chondrogenic Commitment of human Bone Marrow Mesenchymal Stem Cells in a perfused, hTGF-β1-releasing PLGA microcarrier seeded, collagen hydrogel 580
2-deoxy-2-(18F)fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis 526
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 499
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 496
Aplastic anemia: Pathophysiology 491
Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia 481
67 KDA laminin receptor expression in human G-CSF mobilized CD34(+) peripheral blood stem cells correlates with their mobilization efficiency 480
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review 420
Expression and function of the 67kDa laminin receptor in normal and acute leukemia cells 380
Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review 377
Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. 374
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 366
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 361
Immature forms of low density granulocytes are increased in acute myeloid leukemia and myelodysplastic syndromes 346
Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis 338
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 337
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery 326
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 319
High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies 318
All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia 300
A novel approach to cell targeted complement inhibition in PNH: the human complement receptor 2/Factor H fusion protein TT30 prevents both hemolysis and upstream C3-opsonization of PNH erythrocytes 293
Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells 284
Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment 280
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 250
Contribution of peripheral blood mononuclear cells isolated by advanced filtration system to myogenesis of human bone marrow mesenchymal stem cells co-cultured with myoblasts 233
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 219
The urokinase-receptor in infectious diseases. 218
The cleaved form of soluble urokinase-receptor stimulates migration and mobilization of mouse CD34(+) cells in vitro and in vivo 214
Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic Transplantation 211
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 211
Soluble forms of UPAR regulate adhesion, proliferation and survival of KG1 leukemic cells 209
CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples 207
A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells 205
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 200
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 200
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 198
Interleukin-2 therapy in relapsed acute myelogenous leukemia. 197
A backwards evolution in a case of myeloproliferative disease 196
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 195
Function and malfunction of hematopoietic stem cells in primary bone marrow failure syndromes. 188
Bendamustine in combination with rituximab as first line therapy for patients with chronic lymphocytic leukemia (cll): a retrospective real practice italian multicentre study. 185
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 184
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial 184
67 kDa laminin receptor: structure, function and role in cancer and infection. 183
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation 183
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 183
A candidate complement inhibitor for the treatment of paroxysmal nocturnal haemoglobinuria (PNH): preclinical data with tt30, a therapeutic that selectively blocks the complement alternative pathway. 182
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 182
Adjuvant treatment of diabetic foot 181
Continuous alternate-day low dose lenalidomide in combination with low dose prednisone as frontline treatment for octogenarian newly diagnosed multiple myeloma patients 179
Bendamustine in combination with rituximab for elderly patients with aggressive B non hodgkin lymphoma not eligible for anthracycline-based therapy 179
Unresponsiveness to erythropoietin therapy in a case of Blackfan Diamond anemia. 178
A GITMO randomised trial in steroid refractory acute graft-versus-host disease: 6methylprednisolone with or without anti-thymocyte globulin 174
Role of the urokinase receptor in hematopoietic stem cell transplantation 173
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 172
Circulating T Regulatory Cells Are Persistently Reduced in Non-Severe Acquired Aplastic Anemia 171
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 170
The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma 169
A randomized trial of bone marrow (BM) versus peripheral blood (PB) allogeneic hemopoietic stem cell transplants (HSCT) in patients with myeloproliferative disorders. 168
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 166
EFFICACY OF ALEMTUZUMAB PLUS EXTRACORPOREAL PHOTOPHERESIS IN ADVANCED STAGE SEZARY SYNDROME: A CASE REPORT 165
Expression of the 67 kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation 164
A novel chromosomal abnormality detected in a case of acute myelomonocytic leukemia. 163
67 KDa laminin receptor (67LR) expression and function in normal and acute myeloid leukemia CD34(+) cells 163
Involvement of the urokinase receptor in the cross-talk between hematopoietic stem/progenitor cells and the bone marrow microenvironment. 163
Higher expression of Fas receptor on CD34+ cells of chronic myelogenous leukemia correlates with hematological response to IFN-alfa. 161
High frequency of extramedullary relapse in patients transplanted for acute myeloid leukemia. 160
Impact of cytokine gene polymorphism in aplastic anemia (AA) 158
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 158
The role of FAS-mediated apoptosis in chronic myelogenous leukemia. 157
High dose rHuEPO may induce complete remission in AML-M6 157
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 156
Impact of cytokine gene polymorphisms in myelodysplastic syndromes (MDS) 154
Fas-mediated downmodulation of p210 BCR/ABL results in apoptosis of CD34+ cells of chronic myelogenous leukemia. 154
Discovery of new small molecules targeting the vitronectin binding site of the urokinase receptor that block normal and leukemic cell migration 154
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 153
Allogeneic transplantation for multiple myeloma 152
Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion 152
Fluorescent in situ hybridization with a Y probe in the follow up of sex-mismatch transplanted patients 151
Increased expression of the signaling lymphocyte-activation molecule (mSLAM) in patients with paroxysmal nocturnal hemoglobinuria (PNH). 151
Spleen sizing by ultrasound scan and risk of pneumococcal infection in patients with chronic GVHD: preliminary observations. 150
Blockade of intravascular hemolysis in PNH with the terminal complement inhibitor eculizumab unmasks low-level hemolysis potentially occurring through C3 opsonization 149
Two year follow-up of cyclosporin-A in hypoplastic myelodysplastic leukemia. 149
Sirt-1 as a novel therapeutic target for improving nitric oxide release in heterozygous and homozygous patients for mthfr mutations 148
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 148
Estrogen-progestin-replacement therapy in women after stem cell transplant 147
Subcutaneous low-dose IL-2 for remission maintenance in elderly acute myeloid leukemia patients. 147
A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. 146
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey 146
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies 145
Totale 30.543
Salva come PNG Salva come JPEG
Categoria #
all - tutte 168.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.525
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.051 0 9 15 65 58 61 21 74 309 273 267 899
2022/20233.454 333 179 103 358 477 728 52 354 560 22 176 112
2023/20241.769 182 250 131 101 144 264 75 93 16 68 105 340
2024/20254.744 165 77 63 149 223 610 880 501 672 253 500 651
2025/202632.967 2.517 6.957 6.325 1.229 1.973 1.104 3.078 579 4.776 1.791 393 2.245
2026/2027839 626 213 0 0 0 0 0 0 0 0 0 0
Totale 61.486